Nasdaq: IKT
Inhibikase Therapeutics insiders
The officers, directors and 10% owners of Inhibikase Therapeutics, Inc. who hold the most stock, valued at the live IKT price.
$1.30
IKT today −$80K (−5.80%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 0
- Their IKT stock
- $0
- Market value
- $182M
- Held by ranked insiders
- <0.1%
Insiders by value of IKT holdings
SEC ownership pageNo insider of Inhibikase Therapeutics currently holds enough stock to make the list.
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Inhibikase Therapeutics; see each profile for the filing.